Cargando…
Asymmetric dimethylarginine compartmental behavior during high-flux hemodialysis
AIM: The accumulation of uremic toxins, such as asymmetric dimethylarginine (ADMA), has emerged as one of the major cardiovascular disease-related risk factors in patients with end-stage renal disease (ESRD). Based on the low molecular weight of ADMA, hemodialysis (HD) should theoretically effective...
Autores principales: | Du, Qiuna, Gao, Jiayuan, Lu, Renhua, Jin, Yun, Zou, Yanfang, Yu, Chen, Yan, Yucheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470094/ https://www.ncbi.nlm.nih.gov/pubmed/32727241 http://dx.doi.org/10.1080/0886022X.2020.1797790 |
Ejemplares similares
-
Asymmetric and Symmetric Dimethylarginine in Adolescents with Hyperuricemia
por: Tenderenda-Banasiuk, Edyta, et al.
Publicado: (2013) -
Asymmetric Dimethylarginine (ADMA) Levels Are Lower in Hemodialysis Patients Treated With Paricalcitol
por: Oliva-Damaso, Elena, et al.
Publicado: (2016) -
Helicobacter pylori Eradication Lowers Serum Asymmetric Dimethylarginine Levels
por: Aydemir, Selim, et al.
Publicado: (2010) -
Renal Function but Not Asymmetric Dimethylarginine Is Independently Associated with Retinopathy in Type 2 Diabetes
por: Krzyzanowska, Katarzyna, et al.
Publicado: (2011) -
Serum Asymmetric Dimethylarginine, Nitrate, Vitamin B(12), and Homocysteine Levels in Individuals with Pulmonary Embolism
por: Altuntaş, Murat, et al.
Publicado: (2011)